Bioblast Pharma Ltd (NASDAQ:ORPN)

2.21
Delayed Data
As of May 21
 -0.05 / -2.21%
Today’s Change
1.49
Today|||52-Week Range
5.99
-3.32%
Year-to-Date
No recent news for Bioblast Pharma Ltd.

Today’s Trading

Previous close2.26
Today’s open2.55
Day’s range2.13 - 2.55
Volume210,998
Average volume (3 months)235,346
Market cap$8.0M
Data as of 3:59pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)+64.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
TENXTenax Therapeutics I...-0.19-3.14%
CLSNCelsion Corp-0.15-5.38%
IGCIndia Globalization ...-0.00-0.42%
SNGXSoligenix Inc-0.05-2.93%
Data as of 3:59pm ET, 05/21/2018

Financials

Last reporting dateFebruary 23, 2018
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Fredric D. Price
Chief Medical Officer &
Vice President-Research
Warren W. Wasiewski
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts